Navigation Links
Signalife to Deploy Fidelity 100 Heart Monitors for AFL
Date:9/4/2007

LOS ANGELES, Sept. 4 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN) has committed to deploy Fidelity 100 Heart Monitors in more than 12 urban centers to screen for testing of sudden cardiac death and cardiovascular disease, events that will be financed by Athletes for Life, A Non Profit Foundation ("AFL"), through mobile centers though which AFL will bring health care to each community. AFL includes as its founders and members some of the world's greatest living and legendary athletes including, for example, current NFL star Reggie Bush, John Elway, Jim Brown, Marshall Falk, Olympic Gold Medal Winner Maurice Green, Jackie Joyner-Kersee, Gayle Sayers, Lee Elder, Anthony Munoz and Olympic Gold Medal Winner Willie Gault.

The events will be centered around screening and testing patients of all ages in everyday ambulatory environments, when the heart is at work. No other device can measure the full disease spectrum with the accuracy of the fidelity 100 when the subject is moving or when noise (artifact) is present. In the words of Signalife President and Chief Executive, Lowell T. Harmison, "It is impossible to level the playing field without giving everybody an opportunity to identify the signals about their health at the earliest possible opportunity. We are very thankful for AFL's insistence on assuring that the medical community eradicate the current cardiovascular crisis in America where $400 billion is spent annually with paltry preventative results for our middle and lower classes and the majority of society."

Under the arrangement, physicians will be present when AFL conducts its screening programs in various communities. AFL anticipates that it will conduct many of these programs using its prototypical moving "medical center truck". AFL has indicated that additional health care testing and screening will be provided in these centers. This screening program is a continuation of AFL's wellness program initially tested and developed at hea
'/>"/>

SOURCE Signalife, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Signalife Recorder Transmits Heart Rate Data From Champ Car Driver in Real-Time
2. Stress of Deployment Increases Risk of Child Abuse, Neglect in Military Families, UNC Study Shows
3. Dutch Customs Deploys Special Bird Flu Dogs
4. One in Three Heart Attack Patients Have No Chest Pains
5. Epileptic Seizures Can Be Duec to Heart Problem
6. Bypass Heart Surgery Performed Without General Anesthesia
7. New CPR Guidelines issued by Heart Association
8. White Cells Count Can Predict Heart Attack Death Risk
9. Vitamins-The answer to Heart Disease?
10. Fight Heart disease and Pain with Meditation
11. Heart disease in the newborn is related to maternal malnutrition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...s that a child’s race may be a factor in determini...ated with environmental tobacco smoke (ETS). //The... asthma, who are exposed to ETS, have significantl... their Caucasian counterparts. “African American ...
...o experience a change in health caused by an unint...thout insurance are more likely to have difficulty...ely to experience larger declines in short-term he...ey, Ph.D., of the Urban Institute, Washington, D.C...
...ean of University of Massachusetts Medical School ...ealth reasons//. It was reported that he has devel...le for the merger of state hospital and the privat...up the $ 100 million research lab there. In 1982, ...
...kesh Haikerwal, said today the Government must ame...able// elderly Australians from abuse in aged care...ecurity and Protection) Bill 2007, which the Gover... calls for the compulsory reporting of any physica...
Other Medicine News:Health News:Race Affects Tobacco Absorption in Children 2Health News:Uninsured Often Receive Less Medical Care 2Health News:AMA Urges Government To Amend Aged Care Legislation 2
(Date:8/14/2008)...all/ -- Pharmasset, Inc.,(Nasdaq: VRUS ), a clini...overing, developing and commercializing novel drug...nancial results for the third fiscal,quarter ended...ributable to,common stockholders of $15.0 million,...d June 30, 2008, as compared to a net loss attribu...
(Date:8/14/2008)...nable Targeting and Increase Spee.... and HEIDELBERG, Germany, Aug. 14 /-...titute (TGen) today announced,the formation of a c...ration-Sequencing equipment in conjunction with fe..., febit,s HybSelect(TM) Technology enables select...
(Date:8/13/2008)...As biotechnology,pharmaceutical and medical devic...nd their own borders to other parts of the world, ...mplicated regulatory environments,challenge those ...lysis by,Aon Corporation (NYSE: AOC ). Aon,s 2008... a visual representation of the complex insurance,...
(Date:8/13/2008)... to automatically measure QT inter...lif., Aug. 13 /- NewCardio,...stic and services company, today,revealed the resu...no(TM),(the "NCE3 Study"). The study was led by an...t with extensive experience in pharmaceutical clin...
Breaking Medicine Technology:Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4NewCardio Announces Positive Results From Third Clinical Validation Study 2NewCardio Announces Positive Results From Third Clinical Validation Study 3NewCardio Announces Positive Results From Third Clinical Validation Study 4NewCardio Announces Positive Results From Third Clinical Validation Study 5Molecular alliance that sustains embryonic stem cell state 13467 1Molecular alliance that sustains embryonic stem cell state 13467 2Molecular alliance that sustains embryonic stem cell state 13467 3Non Polyp Colon Lesions Hard to Detect 13462 1Non Polyp Colon Lesions Hard to Detect 13462 2Non Polyp Colon Lesions Hard to Detect 13462 3Sticky blood protein yields clues to autism 13458 1Sticky blood protein yields clues to autism 13458 2Sticky blood protein yields clues to autism 13458 3Specialists in drug discovery and development convene 13455 1Specialists in drug discovery and development convene 13455 2
...t Study in American Heart Journal , ,WINNIPEG, Ma...mex:MCU), a cardiovascular focused, biopharmaceuti...llow-up results from the,STRATEGY (Single High-Dos...us Abciximab and Bare Metal Stent In Acute Myocard...dition of the Journal,of the American College of C...
...1, 2007 /PRNewswire/ -- Phase 3 results,from the R...an,etexilate once daily, administered for an avera...o administered for an average of 33,days, in preve...ortality after total hip replacement surgery. In t...ith dabigatran etexilate was,similar to enoxaparin...
Other Medicine Technology:Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5
...e) injection was introduced in 1988, it ushered in...gnetic resonance imaging (MRI). It became the worl...e product is still a market leader with indication...n over 85 countries and has established a positive...
Up to 20% of the 17 million echocardiograms performed annually in the U.S. are suboptimal. Activated DEFINITY increases the power of echocardiography, obtaining clearer images of the heart than with
...neration ultrasound medical diagnostic product wit...ders of the heart. This allows doctors to see abno...asound scanning procedure, enabling more accurate ...viding guidance for the selection and monitoring o...
...isosmolar contrast medium (IOCM™) available ...ood, VISIPAQUE was designed for patient safety and...um formulated with sodium and calcium in a ratio e...A approval for use in children over one year of ag...
Medicine Products: